Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: J Surg Res. 2021 Oct 28;270:293–299. doi: 10.1016/j.jss.2021.09.013

Table 2.

Outcomes

Variables Non-lymphopenic (n = 776) Lymphopenic (n = 618) p-value
Hospital Course
Length of stay (days), median [IQR] 6 [3–13] 9 [5–15] <0.001
ICU days, median [IQR] 4 [2–10] 4 [2–9] 0.797
Ventilator days, median [IQR] 4 [1–10.3] 8 [3–12] 4 [2–9] 0.631
Ventilator-free days, median [IQR] 8 [4–13] 0.376
Complications, n (%)
Pneumonia 104 (13.4) 95 (15.4) 0.317
Urinary Tract Infection 66 (8.5) 60 (9.7) 0.453
Wound Infection 18 (2.3) 14 (2.3) 1.000
Other Infection 17 (2.2) 16 (2.6) 1.000
In-hospital mortality, n (%) 45 (5.8) 60 (9.7) 0.006
Discharge Disposition, n (%) < 0.001
Home 331 (45.3) 169 (30.3)
Home with Health Care 35 (4.8) 39 (7.0)
SNF/Rehab/LTACH 339 (46.4) 340 (60.9)
Other 20 (2.7) 6 (1.1)
Hospice 6 (0.8) 4 (0.7)